140 related articles for article (PubMed ID: 19175039)
1. Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
3. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours.
Stasikowska-Kanicka O; Stawerski P; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(4):174-8. PubMed ID: 20072951
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of hMLH1 and hMSH2 immunohistochemical expression in non-small cell lung cancer. A tissue microarray study.
Skarda J; Fridman E; Plevova P; Hajduch M; Radova L; Ofek E; Kopolovic J; Kolek V; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):255-9. PubMed ID: 17426788
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma].
Zheng JY; Ren TS; Liu B; Wang MN; Liao HH
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):590-4. PubMed ID: 21122410
[TBL] [Abstract][Full Text] [Related]
7. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.
Brown R; Hirst GL; Gallagher WM; McIlwrath AJ; Margison GP; van der Zee AG; Anthoney DA
Oncogene; 1997 Jul; 15(1):45-52. PubMed ID: 9233776
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hMLH1 and hMSH2 proteins in vulvar carcinoma.
Kwasniewska A; Postawski K; Gozdzicka-Józefiak A; Zdunek M; Korobowicz E; Miturski R
Int J Mol Med; 2005 Jun; 15(6):955-61. PubMed ID: 15870899
[TBL] [Abstract][Full Text] [Related]
10. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
[TBL] [Abstract][Full Text] [Related]
11. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
13. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance.
Kouso H; Yoshino I; Miura N; Takenaka T; Ohba T; Yohena T; Osoegawa A; Shoji F; Maehara Y
J Surg Oncol; 2008 Oct; 98(5):377-83. PubMed ID: 18646042
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma.
Rosen DG; Cai KQ; Luthra R; Liu J
Mod Pathol; 2006 Nov; 19(11):1414-20. PubMed ID: 16941012
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer].
Słomka M; Stasikowska O; Wagrowska-Danilewicz M; Danilewicz M; Małecka-Panas E
Pol Merkur Lekarski; 2010 Dec; 29(174):351-6. PubMed ID: 21298983
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry detects mismatch repair gene defects in colorectal cancer.
Hameed F; Goldberg PA; Hall P; Algar U; van Wijk R; Ramesar R
Colorectal Dis; 2006 Jun; 8(5):411-7. PubMed ID: 16684085
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hMSH2 and hMLH1 in stomach cancer and their correlation with Helicobacter pylori infection].
Ma JM; Wang ZH; Liu M; Wang M; Zhang Y; Lu S; Liu LN; Xu GW
Ai Zheng; 2004 May; 23(5):535-9. PubMed ID: 15142449
[TBL] [Abstract][Full Text] [Related]
19. Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients.
Scartozzi M; De Nictolis M; Galizia E; Carassai P; Bianchi F; Berardi R; Gesuita R; Piga A; Cellerino R; Porfiri E
Eur J Cancer; 2003 May; 39(8):1144-9. PubMed ID: 12736115
[TBL] [Abstract][Full Text] [Related]
20. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
